Synthetic lethality across normal tissues is strongly associated with cancer risk, onset, and tumor suppressor specificity.

ABSTRACT: Various characteristics of cancers exhibit tissue specificity, including lifetime cancer risk, onset age, and cancer driver genes. Previously, the large variation in cancer risk across human tissues was found to strongly correlate with the number of stem cell divisions and abnormal DNA methylation levels. Here, we study the role of synthetic lethality in cancer risk. Analyzing normal tissue transcriptomics data in the Genotype-Tissue Expression project, we quantify the extent of co-inactivation of cancer synthetic lethal (cSL) gene pairs and find that normal tissues with more down-regulated cSL gene pairs have lower and delayed cancer risk. Consistently, more cSL gene pairs become up-regulated in cells treated by carcinogens and throughout premalignant stages in vivo. We also show that the

SUBMITTER: Cheng K 

PROVIDER: S-EPMC7775773 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature